Role of CYP2C9 polymorphism in phenytoin-related metabolic abnormalities and subclinical atherosclerosis in young adult epileptic patients

Seizure

Volumn 22, Issue 2, 2013, Pages 103-108

  Phabphal, Kanitpong ^a   Geater, Alan ^a   Limapichart, Kitti ^a   Sathirapanya, Pornchai ^a   Setthawatcharawanich, Suwanna ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

CYP2C9; Epileptic patients; Glucose homeostasis; Lipid profile; Phenytoin; Thailand

Indexed keywords

CYTOCHROME P450 2C9; GENOMIC DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; PHENYTOIN; TRIACYLGLYCEROL;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EPILEPSY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LABORATORY TEST; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METABOLIC DISORDER; MONOTHERAPY; OBESITY; PRIORITY JOURNAL; TREATMENT DURATION;

ADULT; ANTICONVULSANTS; ARYL HYDROCARBON HYDROXYLASES; ATHEROSCLEROSIS; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; PHENYTOIN; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 84873410848     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2012.10.013     Document Type: Article

References (23)

1. J.O. Elliott, M.P. Jacobson, and Z. Haneef Cardiovascular risk factors and homocysteine in epilepsy Epilepsy Research 76 2007 113 123
2. E.P. Calandre, B. Sinues Porta, and D. Garcia de la Calzada The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients Epilepsia 33 1992 154 157
3. S. Mintzer, C.T. Skidmore, C.J. Abidin, M.C. Morales, D.M. Chervoneval, and M.R. Sperling Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein Annals of Neurology 65 2009 448 456
4. K. Phabphal, K. Limapichart, P. Sathirapanya, S. Setthawatcharanich, and A. Geater Characterization of glucose homeostasis and lipid profile in adult, seizure-free, epileptic patients in Asian population European Journal of Neurology 19 2012 1228 1234
5. C. Trocho, J. Escolà-Gil, V. Ribas, S. Benítez, J.M. Martín-Campos, and L. Osaba Phenytoin treatment reduces atherosclerosis in mice through mechanisms independent of plasma HDL-cholesterol concentration Atherosclerosis 174 2004 275 285
6. B. Fisslthaler, R. Popp, L. Kiss, M. Potente, D.R. Harder, and I. Fleming Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 401 1999 493 497
7. I. Fleming, U.R. Michaelis, D. Bredenkötter, B. Fisslthaler, F. Dehghani, and R.P. Brandes Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries Circulation Research 88 2001 44 51
8. E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, and L. Zenari HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study Diabetes Care 25 2002 1135 1141
9. H. Ohnishi, S. Saitoh, N. Ura, S. Takagi, F. Obara, and H. Akasaka Relationship between insulin resistance and accumulation of coronary risk factors Diabetes, Obesity and Metabolism 4 2002 388 393
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
11. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, and J.L. Halperin ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 2006 e463 e654
12. K. Ramasamy, S.K. Narayan, S. Chanolean, and A. Chandrassekaran Severe phenytoin toxicity in a CYP2C9*3*3 homozygous mutant from India Neurology India 55 2007 408 409
13. G.D. Anderson Pharmacogenetics and enzyme inducer/inhibition properties of antiepileptic drugs Neurology 23 Suppl. 4 2004 S3 S8
14. S. Kuanprasert, S. Dettrairat, P. Palacajornsuk, W. Kunachiwa, and A. Phorommintikul Prevalence of CYP2C9 and VKORC1 mutation in patients with valvular disease in Northern Thailand Journal of the Medical Association of Thailand 92 12 2009 1597 1601
15. D.G. Hackan, and S.S. Anand Emerging risk factors for atherosclerotic vascular disease a critical review of the evidence JAMA 290 2003 932 940
16. T. Nikolaos, G. Stylianos, N. Chryssoula, P. Irini, M. Christos, and T. Dimtrios The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL LDL) and triglyceride levels in adult epileptic patients on monotherapy Medical Science Monitor 10 2004 MT50 MT52
17. S.A. Hamed, E.A. Hamed, R. Hamdy, and T. Nabeshima Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy Epilepsy Research 74 2007 183 192
18. T.Y. Tan, C.H. Lu, H.Y. Chuang, T.K. Lin, C.W. Liou, and W.N. Chang Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis Epilepsia 50 2009 1579 1586
19. P.V. Louma, E.A. Sotaniemi, R.O. Peklonen, and V.V. Myllylä Plasma high-density lipoprotein cholesterol and hepatic cytochrome P450 concentrations in epileptics undergoing anticonvulsant treatment Scandinavian Journal of Clinical and Laboratory Investigation 40 1980 163 167
20. J.S. Kizer, M. Vargas-Gordon, K. Brendel, and R. Bressler The in vitro inhibition of insulin secretion by diphenylhydantoin Journal of Clinical Investigation 49 1970 1942 1948
21. N. Callaghan, M. Feely, F. Duggan, M. O'Callaghan, and J. Seldruo The effects of toxic and non-toxic serum phenytoin levels on carbohydrate tolerance and insulin levels Acta Neurologica Scandinavica 56 1977 563 571
22. C.M. Castleden, and A. Richens Letter: chronic phenytoin therapy and carbohydrate tolerance Lancet 2 1973 966 967
23. K. Tziomalos, V.G. Athyros, A. Karagiannis, and D.P. Mikhailidis The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification Current Opinion in Cardiology 25 2010 394 398